Unaudited Condensed Consolidated Statement of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net loss	$ (18,994,000)	$ (21,261,000)
Adjustments to reconcile net loss to net cash (used in) provided by operations:
Share-based compensation	9,467,000	7,401,000
Depreciation and amortization	1,816,000	1,789,000
Amortization of right-of-use assets	643,000	845,000
Loss on impairment of long lived assets	0	536,000
Impairment of right-of-use assets	186,000	0
Allowance for doubtful accounts	109,000	122,000
Change in fair value of warrant liabilities	(4,447,000)	(168,000)
Changes in operating assets and liabilities:
Accounts receivable	(1,596,000)	135,000
Prepaid expenses and other assets	1,125,000	2,446,000
Accounts payable	1,066,000	(1,377,000)
Accrued expenses and other liabilities	2,782,000	(403,000)
Accrued compensation and benefits	(3,967,000)	(6,731,000)
Operating lease liabilities	(555,000)	(1,049,000)
Other	(10,000)	0
Net cash used in operating activities	(12,375,000)	(17,715,000)
Cash flows from investing activities:
Purchases of property and equipment	(400,000)	(71,000)
Net cash used in investing activities	(400,000)	(71,000)
Cash flows from financing activities:
Proceeds from exercise of options	226,000	61,000
Taxes withheld and paid related to net share settlement of equity awards	(2,302,000)	(557,000)
Net cash used in financing activities	(2,076,000)	(496,000)
Effect of changes in currency exchange rates on cash and cash equivalents	(253,000)	228,000
Net decrease in cash and cash equivalents	(15,104,000)	(18,054,000)
Cash, cash equivalents and restricted cash, beginning of the period	145,785,000	194,965,000
Cash, cash equivalents and restricted cash, end of the period	130,681,000	176,911,000
Reconciliation of cash, cash equivalents and restricted cash to the amounts reported within the consolidated balance sheets
Cash and cash equivalents	129,606,000	175,268,000
Restricted cash	1,075,000	1,643,000
Total cash, cash equivalents and restricted cash, end of the period	130,681,000	176,911,000
Supplemental disclosure of non-cash investing and financing activities:
Lease liabilities arising from obtaining right-of-use assets	4,506,000	0
Vesting of early exercised stock options and restricted stock awards	36,000	131,000
Property and equipment purchases not yet paid	$ 25,000	$ 0